Table 3. Frequency distribution of the results of morphological analyses according to the group and time of sacrifice (LBO/UFBA, 2022).
| Variable | Results | G1 | G2 | G3 | G4 | G5 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 days | 7 days | 14 days | 3 days | 7 days | 14 days | 3 days | 7 days | 14 days | 3 days | 7 days | 14 days | 3 days | 7 days | 14 days | ||
| n=5 | n=5 | n=5 | n=5 | n=4 | n=5 | n=4 | n=5 | n=5 | n=5 | n=5 | n=5 | n=5 | n=5 | n=5 | ||
| Edema | Absent | 0(0.0%) | 3(60.0%) | 5(100%) | 0(0.0%) | 4(100%) | 5(100%) | 0(0.0%) | 1(20.0%) | 5(100%) | 1(20.0%) | 1(20.0%) | 4(80.0%) | 0(0.0%) | 3(60.0%) | 4(80.0%) |
| Discreet | 0(0.0%) | 2(40.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 3(60.0%) | 0(0.0%) | 0(0.0%) | 2(40.0%) | 0(0.0%) | 0(0.0%) | 1(20.0%) | 0(0.0%) | |
| Moderate | 0(0.0%) | 0(0.0%) | 0(0.0%) | 3(60.0%) | 0(0.0%) | 0(0.0%) | 1(25.0%) | 1(20.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | |
| Intense | 5(100%) | 0(0,0%) | 0(0.0%) | 2(40.0%) | 0(0.0%) | 0(0.0%) | 3(75.0%) | 0(0.0%) | 0(0.0%) | 4(80.0%) | 2(40.0%) | 1(20.0%) | 5(100%) | 1(20.0%) | 1(20.0%) | |
| Inflamma-tory infiltrate | Absent | 0(0.0%) | 0(0.0%) | 1(20.0%) | 0(0.0%) | 4(100%) | 2(40.0%) | 0(0.0%) | 0(0.0%) | 2(40.0%) | 1(20.0%) | 1(20.0%) | 1(20.0%) | 0(0.0%) | 0(0.0%) | 3(60.0%) |
| Discreet | 0(0.0%) | 0(0.0%) | 4(80.0%) | 0(0.0%) | 0(0.0%) | 3(60.0%) | 0(0.0%) | 1(20.0%) | 1(20.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 3(60.0%) | 0(0.0%) | |
| Moderate | 3(60.0%) | 2(40.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 2(50.0%) | 0(0.0%) | 2(40.0%) | 0(0.0%) | 0(0.0%) | 2(40.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | |
| Intense | 2(40.0%) | 3(60.0%) | 0(0.0%) | 5(100%) | 0(0.0%) | 0(0.0%) | 2(50.0%) | 4(80.0%) | 0(0.0%) | 4(80.0%) | 4(80.0%) | 2(40.0%) | 5(100%) | 2(40.0%) | 1(40.0%) | |
| Characteristics of the infiltrator | Absent | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 4(100%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 2(40.0%) | 0(0.0%) | 1(20.0%) | 1(20.0%) | 0(0.0%) | 0(0.0%) | 3(60.0%) |
| PMN | 5 (100%) | 3(60.0%) | 0(0.0%) | 5(100%) | 0(0.0%) | 0(0.0%) | 5(100%) | 4(80.0%) | 1(20.0%) | 5(100%) | 0(0.0%) | 0(0.0%) | 5(100%) | 1(20.0%) | 0(0.0%) | |
| MMN | 0(0.0%) | 2(40.0%) | 5 (100%) | 0(0.0%) | 0(0.0%) | 5(100%) | 0(0.0%) | 1(20.0%) | 2(40.0%) | 0(0.0%) | 4(80.0%) | 4(80.0%) | 0(0.0%) | 4(80.0%) | 2(40.0%) | |
| Cellularity | Absent | 0(0.0%) | 0(0.0%) | 0(0.0%) | 5(100%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 4(80.0%) | 4(80.0%) | 3(60.0%) | 5(100%) | 2(40.0%) | 1(20.0%) |
| Discreet | 5(100%) | 3(60.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 4(100%) | 3(60.0%) | 1(20.0%) | 1(20.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 1(20.0%) | |
| Moderate | 0(0.0%) | 2(40.0%) | 3(60.0%) | 0(0.0%) | 4(100%) | 3(60.0%) | 0(0.0%) | 1(20.0%) | 2(40.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 2(40.0%) | 1(20.0%) | |
| Intense | 0(0.0%) | 0(0.0%) | 2(40.0%) | 0(0.0%) | 0(0.0%) | 2(40.0%) | 0(0.0%) | 1(20.0%) | 2(40.0%) | 0(0.0%) | 1(20.0%) | 2(40.0%) | 0(0.0%) | 1(20.0%) | 2(40.0%) | |
| Re-epithelialization | Absent | 5(100%) | 3(60.0%) | 0(0.0%) | 5(100%) | 0(0.0%) | 0(0.0%) | 2(50.0%) | 0(0.0%) | 0(0.0%) | 3(60.0%) | 2(40.0%) | 2(40.0%) | 5(100%) | 1(20.0%) | 1(20.0%) |
| Partial | 0(0.0%) | 2(40.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 2(50.0%) | 2(20.0%) | 0(0.0%) | 2(40.0%) | 2(40.0%) | 0(0.0%) | 0(0.0%) | 1(20.0%) | 0(0.0%) | |
| CDis | 0(0.0%) | 0(0.0%) | 2(40.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 1(20.0%) | 3(60.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | |
| COrg | 0(0.0%) | 0(0.0%) | 3(60.0%) | 0(0.0%) | 4(100%) | 5(100%) | 0(0.0%) | 2(40.0%) | 2(40.0%) | 0(0.0%) | 1(20.0%) | 3(60.0%) | 0(0.0%) | 3(60.0%) | 4(80.0%) | |
Descriptive analysis (percentage). CDis: complete disorganized; COrg: complete organized; PMN: polymorphonuclear; MNN: monomorphonuclear. Source: own authorship.